Brinker Capital Investments, LLC Abb Vie Inc. Transaction History

Brinker Capital Investments, LLC

$5.01 Billion
Q4 2022

A detailed history of Brinker Capital Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 82,126 shares of ABBV stock, worth $16.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

82,126

Previous 85,569 4.02%

Holding current value

$16.2 Million

Previous $11.5 Million 15.63%

% of portfolio

0.27%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $476,201 - $571,090	-3,443 Reduced 4.02%	82,126 $13.3 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $949,804 - $1.09 Million	-7,077 Reduced 7.64%	85,569 $11.5 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $2.1 Million - $2.67 Million	-15,269 Reduced 14.15%	92,646 $14.2 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.48 Million - $1.84 Million	-11,228 Reduced 9.42%	107,915 $17.5 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $3.58 Million - $4.53 Million	33,316 Added 38.82%	119,143 $16.1 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $27,132 - $30,798	-255 Reduced 0.3%	85,827 $9.63 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $1.64 Million - $1.82 Million	15,549 Added 22.05%	86,082 $9.7 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $1.8 Million - $1.99 Million	17,626 Added 33.32%	70,533 $7.63 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1.46 Million - $1.97 Million	-18,126 Reduced 25.52%	52,907 $5.67 Million
Q3 2020 Dec 03, 2020	BUY	$85.91 - $100.83 $5.24 Million - $6.15 Million	60,961 Added 605.25%	71,033 $6.22 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $87,823 - $117,521	-1,197 Reduced 10.62%	10,072 $989,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $597,915 - $906,513	-9,270 Reduced 45.13%	11,269 $859,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $53,159 - $66,514	-737 Reduced 3.46%	20,539 $1.82 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $54,981 - $66,103	873 Added 4.28%	21,276 $1.61 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $209,517 - $267,812	-3,189 Reduced 13.52%	20,403 $1.48 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $178,270 - $209,815	2,311 Added 10.86%	23,592 $1.9 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $14,480 - $17,857	-186 Reduced 0.87%	21,281 $1.96 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $211,427 - $235,041	2,378 Added 12.46%	21,467 $2.03 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $180,278 - $213,309	2,008 Added 11.76%	19,089 $1.77 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $4,508 - $6,037	49 Added 0.29%	17,081 $1.62 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $447 - $491	-5 Reduced 0.03%	17,032 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $48,755 - $62,275	698 Added 4.27%	17,037 $1.51 Million
Q2 2017 Aug 08, 2017	BUY	N/A	16,339	16,339 $1.19 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Abb Vie Inc. Transaction History